Cargando…

FBXO43 increases CCND1 stability to promote hepatocellular carcinoma cell proliferation and migration

BACKGROUND AND AIMS: Abnormal expression of E3 ubiquitin ligase plays an important role in the development and progression of hepatocellular carcinoma (HCC), although the mechanism has remained elusive. This study aimed to investigate the biological function and potential mechanism of FBXO43 in HCC....

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Chun-Ming, Zhang, Jie, Wu, Wu, Zhu, Zhu, Li, Feng, Wu, Di, Wang, Xiao-Jun, Xie, Chuan-Ming, Gong, Jian-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020529/ https://www.ncbi.nlm.nih.gov/pubmed/36937431 http://dx.doi.org/10.3389/fonc.2023.1138348

Ejemplares similares

Clinical significance of FBXO43 in hepatocellular carcinoma and its impact on tumor cell proliferation, migration and invasion
por: Ma, Rulan, et al.
Publicado: (2023)

FGF19 Is Coamplified With CCND1 to Promote Proliferation in Lung Squamous Cell Carcinoma and Their Combined Inhibition Shows Improved Efficacy
por: Zhang, Yanshuang, et al.
Publicado: (2022)

FBXO9 Mediates the Cancer-Promoting Effects of ZNF143 by Degrading FBXW7 and Facilitates Drug Resistance in Hepatocellular Carcinoma
por: Wang, Zhenyu, et al.
Publicado: (2022)

Downregulation of the FBXO43 gene inhibits tumor growth in human breast cancer by limiting its interaction with PCNA
por: Ma, Rulan, et al.
Publicado: (2021)

Knockdown of NDUFC1 inhibits cell proliferation, migration, and invasion of hepatocellular carcinoma
por: Han, Fang, et al.
Publicado: (2022)

Case report: Identification of atypical mantle cell lymphoma with CCND3 rearrangement by next-generation sequencing
por: Dai, Luomengjia, et al.
Publicado: (2023)

UCHL3 promotes hepatocellular carcinoma cell migration by de-ubiquitinating and stabilizing Vimentin
por: Ma, Qiancheng, et al.
Publicado: (2023)

In vivo analysis of FBXO45-mediated fibrosis and liver tumorigenesis in a chemically induced mouse model of hepatocellular carcinoma
por: Zhang, Jie, et al.
Publicado: (2023)

FBXO17 Inhibits the Wnt/β-Catenin Pathway and Proliferation of Ishikawa Cells
por: Zheng, Zi-Meng, et al.
Publicado: (2022)

Inhibition of EGR1 inhibits glioma proliferation by targeting CCND1 promoter
por: Chen, Dian-gang, et al.
Publicado: (2017)

LINC00494 Promotes Ovarian Cancer Development and Progression by Modulating NFκB1 and FBXO32
por: Shu, Yang, et al.
Publicado: (2021)

OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma
por: Cao, Lu, et al.
Publicado: (2013)

Advances of Targeted Therapy for Hepatocellular Carcinoma
por: Niu, Mengke, et al.
Publicado: (2021)

Targeting TRIM54/Axin1/β-Catenin Axis Prohibits Proliferation and Metastasis in Hepatocellular Carcinoma
por: Zhu, Jinrong, et al.
Publicado: (2021)

Suppression of Heterogeneous Nuclear Ribonucleoprotein C Inhibit Hepatocellular Carcinoma Proliferation, Migration, and Invasion via Ras/MAPK Signaling Pathway
por: Hu, Jiejun, et al.
Publicado: (2021)

Stemness Analysis Uncovers That The Peroxisome Proliferator-Activated Receptor Signaling Pathway Can Mediate Fatty Acid Homeostasis In Sorafenib-Resistant Hepatocellular Carcinoma Cells
por: Feng, Tingze, et al.
Publicado: (2022)

CCND1, NOP14 and DNMT3B are involved in miR‐502‐5p–mediated inhibition of cell migration and proliferation in bladder cancer
por: Ying, Yufan, et al.
Publicado: (2020)

lncRNA NEAT1 promotes the proliferation and metastasis of hepatocellular carcinoma by regulating the FOXP3/PKM2 axis
por: Pan, Junping, et al.
Publicado: (2022)

N(6)-Methyladenosine Associated Silencing of miR-193b Promotes Cervical Cancer Aggressiveness by Targeting CCND1
por: Huang, Chunxian, et al.
Publicado: (2021)

Downregulation of miR-193a-3p is involved in the pathogenesis of hepatocellular carcinoma by targeting CCND1
por: Wang, Shi-shuo, et al.
Publicado: (2020)

LncRNA KASRT Serves as a Potential Treatment Target by Regulating SRSF1-Related KLF6 Alternative Splicing and the P21/CCND1 Pathway in Osteosarcoma: An In Vitro and In Vivo Study
por: Chen, Kai, et al.
Publicado: (2021)

PCDH9 suppresses melanoma proliferation and cell migration
por: Zhang, Jiaojiao, et al.
Publicado: (2022)

Effect of CRISPR Knockout of AXIN1 or ARID1A on Proliferation and Migration of Porcine Hepatocellular Carcinoma
por: Elkhadragy, Lobna, et al.
Publicado: (2022)

CCND2 mRNA Expression Is Correlated With R-CHOP Treatment Efficacy and Prognosis in Patients With ABC-DLBCL
por: Wang, Di, et al.
Publicado: (2020)

High Expression of PAMR1 Predicts Favorable Prognosis and Inhibits Proliferation, Invasion, and Migration in Cervical Cancer
por: Yang, Rui, et al.
Publicado: (2021)

FBXO22 degrades nuclear PTEN to promote tumorigenesis
por: Ge, Meng-Kai, et al.
Publicado: (2020)

MiR-193a-3p inhibits pancreatic ductal adenocarcinoma cell proliferation by targeting CCND1
por: Chen, Zhi-Min, et al.
Publicado: (2019)

Inhibition of Glyoxalase-I Leads to Reduced Proliferation, Migration and Colony Formation, and Enhanced Susceptibility to Sorafenib in Hepatocellular Carcinoma
por: Michel, Maurice, et al.
Publicado: (2019)

Let-7i-3p inhibits the cell cycle, proliferation, invasion, and migration of colorectal cancer cells via downregulating CCND1
por: Tu, Fei, et al.
Publicado: (2022)

MicroRNA-210 interacts with FBXO31 to regulate cancer proliferation cell cycle and migration in human breast cancer
por: Liu, Dayue, et al.
Publicado: (2016)

Emerging role of FBXO22 in carcinogenesis
por: Cheng, Jiangting, et al.
Publicado: (2020)

A novel therapeutic strategy of combined camrelizumab and apatinib for the treatment of advanced hepatocellular carcinoma
por: Yang, Qing, et al.
Publicado: (2023)

F-box protein FBXO22 mediates polyubiquitination and degradation of KLF4 to promote hepatocellular carcinoma progression
por: Tian, Xin, et al.
Publicado: (2015)

CK-3, A Novel Methsulfonyl Pyridine Derivative, Suppresses Hepatocellular Carcinoma Proliferation and Invasion by Blocking the PI3K/AKT/mTOR and MAPK/ERK Pathways
por: Wu, Qiong, et al.
Publicado: (2021)

Methylation-mediated silencing of EDN3 promotes cervical cancer proliferation, migration and invasion
por: Zhu, Peng, et al.
Publicado: (2023)

PSMC2/CCND1 axis promotes development of ovarian cancer through regulating cell growth, apoptosis and migration
por: Zhu, Dawei, et al.
Publicado: (2021)

MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2
por: Li, Yan-Li, et al.
Publicado: (2016)

FBXO28 promotes proliferation, invasion, and metastasis of pancreatic cancer cells through regulation of SMARCC2 ubiquitination
por: Liu, Songbai, et al.
Publicado: (2023)

Reclassification of Hepatocellular Cancer With Neural-Related Genes
por: Zhang, Yi-Gan, et al.
Publicado: (2022)

Regulation of FBXO4-mediated ICAM-1 protein stability in metastatic breast cancer
por: Kang, Jae-Hyeok, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_norqs1g0vgpp5ok184iiufrt0k